Combinatorial G-CSF/AMD3100 treatment in cardiac repair after myocardial infarction

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Rüder, Constantin ^a,b   Haase, Tobias ^a,b   Krost, Annalena ^a   Langwieser, Nicole ^a,c   Peter, Jan ^a   Kamann, Stefanie ^a   Zohlnhöfer, Dietlind ^a,b  

^a Berlin Brandenburg Center for Regenerative Therapies ^*  (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c LILLY DEUTSCHLAND GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; PLERIXAFOR; HETEROCYCLIC COMPOUND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG TREATMENT FAILURE; ENDOTHELIAL PROGENITOR CELL; FLOW CYTOMETRY; HEART HEMODYNAMICS; HEART INFARCTION; HEART INFARCTION SIZE; LEUKOCYTE; MOUSE; NONHUMAN; SINGLE DRUG DOSE; SURVIVAL RATE; TREATMENT DURATION; VASCULARIZATION; ANIMAL; DISEASE MODEL; DRUG COMBINATION; HEART; MALE; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; GRANULOCYTE COLONY-STIMULATING FACTOR; HEART; HETEROCYCLIC COMPOUNDS; MALE; MICE; MYOCARDIAL INFARCTION;

EID: 84940258578     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104644     Document Type: Article

References (58)

1. Guo Y, Graham-Evans B, Broxmeyer HE (2006) Murine embryonic stem cells secrete cytokines/growth modulators that enhance cell survival/anti-apoptosis and stimulate colony formation of murine hematopoietic progenitor cells. Stem Cells 24: 850-856. (Pubitemid 44464718)
2. Basu S, Broxmeyer HE (2005) Transforming growth factor-{beta}1 modulates responses of CD34+ cord blood cells to stromal cell-derived factor-1/CXCL12. Blood 106: 485-493. (Pubitemid 40981242)
3. Yu RY, Wang X, Pixley FJ, Yu JJ, Dent AL, et al. (2005) BCL-6 negatively regulates macrophage proliferation by suppressing autocrine IL-6 production. Blood 105: 1777-1784. (Pubitemid 40223702)
4. Moazzami K, Roohi A, Moazzami B (2013) Granulocyte colony stimulating factor therapy for acute myocardial infarction. Cochrane Database Syst Rev 5: CD008844.
5. Sanganalmath SK, Abdel-Latif A, Bolli R, Xuan YT, Dawn B (2011) Hematopoietic cytokines for cardiac repair: mobilization of bone marrow cells and beyond. Basic Res Cardiol 106: 709-733.
6. Zohlnhofer D (2008) G-CSF for left ventricular recovery after myocardial infarction: is it time to face reality? Cardiovasc Drugs Ther 22: 343-345.
7. Stein A, Zohlnhofer D, Pogatsa-Murray G, von Wedel J, Steppich BA, et al. (2010) Expression of CXCR4, VLA-1, LFA-3 and transducer of ERB in G-CSF-mobilised progenitor cells in acute myocardial infarction. Thromb Haemost 103: 638-643.
8. Broxmeyer HE, Orschell CM, Clapp DW, Hangoc G, Cooper S, et al. (2005) Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 201: 1307-1318. (Pubitemid 40629073)
9. Calandra G, McCarty J, McGuirk J, Tricot G, Crocker SA, et al. (2008) AMD3100 plus G-CSF can successfully mobilize CD34+ cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data. Bone Marrow Transplant 41: 331-338. (Pubitemid 351330727)
10. Brave M, Farrell A, Ching Lin S, Ocheltree T, Pope Miksinski S, et al. (2010) FDA review summary: Mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation. Oncology 78: 282-288.
11. Capoccia BJ, Shepherd RM, Link DC (2006) G-CSF and AMD3100 mobilize monocytes into the blood that stimulate angiogenesis in vivo through a paracrine mechanism. Blood 108: 2438-2445. (Pubitemid 44497531)
12. Jujo K, Hamada H, Iwakura A, Thorne T, Sekiguchi H, et al. (2010) CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc Natl Acad Sci U S A 107: 11008-11013.
13. Misao Y, Takemura G, Arai M, Ohno T, Onogi H, et al. (2006) Importance of recruitment of bone marrow-derived CXCR4+ cells in post-infarct cardiac repair mediated by G-CSF. Cardiovasc Res 71: 455-465. (Pubitemid 44107862)
14. Theiss HD, Vallaster M, Rischpler C, Krieg L, Zaruba MM, et al. (2011) Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis. Stem Cell Res 7: 244-255.
15. Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, et al. (2004) Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 110: 3300-3305. (Pubitemid 39557491)
16. Rüder C, Haase T, Krost A, Langwieser N, Böttcher S, et al. (2014) Combinatorial treatment with VEGF and AMD3100 promotes cardiac repair after myocardial infarction by enhanced neovascularization. In press.
17. Steendijk P, Staal E, Jukema JW, Baan J (2001) Hypertonic saline method accurately determines parallel conductance for dual-field conductance catheter. Am J Physiol Heart Circ Physiol 281: H755-763.
18. Zaruba MM, Huber BC, Brunner S, Deindl E, David R, et al. (2008) Parathyroid hormone treatment after myocardial infarction promotes cardiac repair by enhanced neovascularization and cell survival. Cardiovasc Res 77: 722-731. (Pubitemid 351301860)
19. Takagawa J, Zhang Y, Wong ML, Sievers RE, Kapasi NK, et al. (2007) Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches. J Appl Physiol (1985) 102: 2104-2111.
20. Cheng Z, Ou L, Liu Y, Liu X, Li F, et al. (2008) Granulocyte colony-stimulating factor exacerbates cardiac fibrosis after myocardial infarction in a rat model of permanent occlusion. Cardiovasc Res 80: 425-434.
21. Deten A, Volz HC, Clamors S, Leiblein S, Briest W, et al. (2005) Hematopoietic stem cells do not repair the infarcted mouse heart. Cardiovasc Res 65: 52-63. (Pubitemid 40038478)
22. Harada M, Qin Y, Takano H, Minamino T, Zou Y, et al. (2005) G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 11: 305-311. (Pubitemid 40460559)
23. Hasegawa H, Takano H, Iwanaga K, Ohtsuka M, Qin Y, et al. (2006) Cardioprotective effects of granulocyte colony-stimulating factor in swine with chronic myocardial ischemia. J Am Coll Cardiol 47: 842-849. (Pubitemid 43243110)
24. Miki T, Miura T, Nishino Y, Yano T, Sakamoto J, et al. (2004) Granulocyte colony stimulating factor/macrophage colony stimulating factor improves postinfarct ventricular function by suppression of border zone remodelling in rats. Clin Exp Pharmacol Physiol 31: 873-882. (Pubitemid 40052312)
25. Ohtsuka M, Takano H, Zou Y, Toko H, Akazawa H, et al. (2004) Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularization. FASEB J 18: 851-853.
26. Sugano Y, Anzai T, Yoshikawa T, Maekawa Y, Kohno T, et al. (2005) Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction. Cardiovasc Res 65: 446-456. (Pubitemid 40082487)
27. Werneck-de-Castro JP, Costa ESRH, de Oliveira PF, Pinho-Ribeiro V, Mello DB, et al. (2006) G-CSF does not improve systolic function in a rat model of acute myocardial infarction. Basic Res Cardiol 101: 494-501. (Pubitemid 44637865)
28. Bocchi L, Savi M, Graiani G, Rossi S, Agnetti A, et al. (2011) Growth factor-induced mobilization of cardiac progenitor cells reduces the risk of arrhythmias, in a rat model of chronic myocardial infarction. PLoS One 6: e17750.
29. Badorff C, Brandes RP, Popp R, Rupp S, Urbich C, et al. (2003) Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 107: 1024-1032. (Pubitemid 36258727)
30. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, et al. (2001) Bone marrow cells regenerate infarcted myocardium. Nature 410: 701-705. (Pubitemid 32290358)
31. Takamiya M, Haider KH, Ashraf M (2011) Identification and characterization of a novel multipotent sub-population of Sca-1(+) cardiac progenitor cells for myocardial regeneration. PLoS One 6: e25265.
32. Gruh I, Beilner J, Blomer U, Schmiedl A, Schmidt-Richter I, et al. (2006) No evidence of transdifferentiation of human endothelial progenitor cells into cardiomyocytes after coculture with neonatal rat cardiomyocytes. Circulation 113: 1326-1334. (Pubitemid 43739454)
33. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, et al. (2004) Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428: 664-668. (Pubitemid 38524810)
34. Gnecchi M, He H, Liang OD, Melo LG, Morello F, et al. (2005) Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11: 367-368. (Pubitemid 40562318)
35. Huang C, Gu H, Yu Q, Manukyan MC, Poynter JA, et al. (2011) Sca-1+ cardiac stem cells mediate acute cardioprotection via paracrine factor SDF-1 following myocardial ischemia/reperfusion. PLoS One 6: e29246.
36. Minatoguchi S, Takemura G, Chen XH, Wang N, Uno Y, et al. (2004) Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment. Circulation 109: 2572-2580.
37. Lian WS, Lin H, Cheng WT, Kikuchi T, Cheng CF (2011) Granulocyte-CSF induced inflammation-associated cardiac thrombosis in iron loading mouse heart and can be attenuated by statin therapy. J Biomed Sci 18: 26.
38. Hu J, Takatoku M, Sellers SE, Agricola BA, Metzger ME, et al. (2002) Analysis of origin and optimization of expansion and transduction of circulating peripheral blood endothelial progenitor cells in the rhesus macaque model. Hum Gene Ther 13: 2041-2050. (Pubitemid 35417349)
39. Powell TM, Paul JD, Hill JM, Thompson M, Benjamin M, et al. (2005) Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 25: 296-301. (Pubitemid 40189148)
40. Zohlnhofer D, Ott I, Mehilli J, Schomig K, Michalk F, et al. (2006) Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA 295: 1003-1010.
41. Shepherd RM, Capoccia BJ, Devine SM, Dipersio J, Trinkaus KM, et al. (2006) Angiogenic cells can be rapidly mobilized and efficiently harvested from the blood following treatment with AMD3100. Blood 108: 3662-3667. (Pubitemid 44864542)
42. Stroncek DF, Clay ME, Herr G, Smith J, Jaszcz WB, et al. (1997) The kinetics of G-CSF mobilization of CD34+ cells in healthy people. Transfus Med 7: 19-24. (Pubitemid 27141041)
43. Roberts AW, DeLuca E, Begley CG, Basser R, Grigg AP, et al. (1995) Broad inter-individual variations in circulating progenitor cell numbers induced by granulocyte colony-stimulating factor therapy. Stem Cells 13: 512-516.
44. Dubois C, Liu X, Claus P, Marsboom G, Pokreisz P, et al. (2010) Differential effects of progenitor cell populations on left ventricular remodeling and myocardial neovascularization after myocardial infarction. J Am Coll Cardiol 55: 2232-2243.
45. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, et al. (1999) Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5: 434-438. (Pubitemid 29180584)
46. Tura O, Crawford J, Barclay GR, Samuel K, Hadoke PW, et al. (2010) Granulocyte colony-stimulating factor (G-CSF) depresses angiogenesis in vivo and in vitro: implications for sourcing cells for vascular regeneration therapy. J Thromb Haemost 8: 1614-1623.
47. Frangogiannis NG, Smith CW, Entman ML (2002) The inflammatory response in myocardial infarction. Cardiovasc Res 53: 31-47. (Pubitemid 34020764)
48. Lichtenauer M, Mildner M, Werba G, Beer L, Hoetzenecker K, et al. (2012) Anti-thymocyte globulin induces neoangiogenesis and preserves cardiac function after experimental myocardial infarction. PLoS One 7: e52101.
49. Roberts R, DeMello V, Sobel BE (1976) Deleterious effects of methylprednisolone in patients with myocardial infarction. Circulation 53: I204-206.
50. Barron HV, Cannon CP, Murphy SA, Braunwald E, Gibson CM (2000) Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 substudy. Circulation 102: 2329-2334.
51. Maekawa Y, Anzai T, Yoshikawa T, Sugano Y, Mahara K, et al. (2004) Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol 44: 1510-1520. (Pubitemid 39303957)
52. Salem HK, Thiemermann C (2010) Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 28: 585-596.
53. Pitchford SC, Furze RC, Jones CP, Wengner AM, Rankin SM (2009) Differential mobilization of subsets of progenitor cells from the bone marrow. Cell Stem Cell 4: 62-72.
54. Ripa RS, Haack-Sorensen M, Wang Y, Jorgensen E, Mortensen S, et al. (2007) Bone marrow derived mesenchymal cell mobilization by granulocyte-colony stimulating factor after acute myocardial infarction: results from the Stem Cells in Myocardial Infarction (STEMMI) trial. Circulation 116: I24-30. (Pubitemid 47480766)
55. Gorog DA, Tanno M, Kabir AM, Kanaganayagam GS, Bassi R, et al. (2003) Varying susceptibility to myocardial infarction among C57BL/6 mice of different genetic background. J Mol Cell Cardiol 35: 705-708. (Pubitemid 36677454)
56. Guo Y, Flaherty MP, Wu WJ, Tan W, Zhu X, et al. (2012) Genetic background, gender, age, body temperature, and arterial blood pH have a major impact on myocardial infarct size in the mouse and need to be carefully measured and/or taken into account: results of a comprehensive analysis of determinants of infarct size in 1,074 mice. Basic Res Cardiol 107: 288.
57. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, et al. (2001) Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A 98: 10344-10349. (Pubitemid 32803022)
58. England TJ, Gibson CL, Bath PM (2009) Granulocyte-colony stimulating factor in experimental stroke and its effects on infarct size and functional outcome: A systematic review. Brain Res Rev 62: 71-82.